359 related articles for article (PubMed ID: 25503656)
1. Angiographic patterns of restenosis with 2nd generation drug-eluting stent: comparative analysis from a 10-year single-center experience .
Lee S; Yoon CH; Oh IY; Suh JW; Cho YS; Cho GY; Chae IH; Choi DJ; Youn TJ
Int Heart J; 2015; 56(1):6-12. PubMed ID: 25503656
[TBL] [Abstract][Full Text] [Related]
2. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
[TBL] [Abstract][Full Text] [Related]
3. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
4. Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial.
Xu B; Yang Y; Yuan Z; Du Z; Wong SC; Généreux P; Lu S;
JACC Cardiovasc Interv; 2013 Jul; 6(7):664-70. PubMed ID: 23523240
[TBL] [Abstract][Full Text] [Related]
5. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
6. Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses.
Markovic S; Paliskyte R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2012; 13(6):307-10. PubMed ID: 23164475
[TBL] [Abstract][Full Text] [Related]
7. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
[TBL] [Abstract][Full Text] [Related]
8. Long-term comparative analysis from an all-comer cohort of coronary patients treated using first- and second-generation drug-eluting stents.
Codner P; Bental T; Assali A; Vaknin-Assa H; Lev E; Kornowski R
J Invasive Cardiol; 2014 Aug; 26(8):378-84. PubMed ID: 25091097
[TBL] [Abstract][Full Text] [Related]
9. Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease.
Valenti R; Migliorini A; Parodi G; Carrabba N; Vergara R; Dovellini EV; Antoniucci D
J Am Coll Cardiol; 2012 Oct; 60(14):1217-22. PubMed ID: 23017531
[TBL] [Abstract][Full Text] [Related]
10. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
[TBL] [Abstract][Full Text] [Related]
12. Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial.
Jang SJ; Park DW; Kim WJ; Kim YH; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1106-14. PubMed ID: 22899589
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents.
Chieffo A; Foglieni C; Nodari RL; Briguori C; Sangiorgi G; Latib A; Montorfano M; Airoldi F; Michev I; Carlino M; Colombo A; Maseri A
Am J Cardiol; 2009 Dec; 104(12):1660-7. PubMed ID: 19962471
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of everolimus-eluting stents for bare-metal in-stent restenosis.
Ota H; Mahmoudi M; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015; 16(3):151-5. PubMed ID: 25977226
[TBL] [Abstract][Full Text] [Related]
16. Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Richardt G; Valgimigli M; Schulz S; Singh A; Abdel-Wahab M; Tiroch K; Pache J; Hausleiter J; Byrne RA; Ott I; Ibrahim T; Fusaro M; Seyfarth M; Laugwitz KL; Massberg S; Kastrati A;
J Am Coll Cardiol; 2013 Dec; 62(22):2075-82. PubMed ID: 23973699
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents.
Ferenc M; Buettner HJ; Gick M; Comberg T; Rothe J; Khoury F; Valina C; Toma A; Kuebler P; Riede F; Neumann FJ
Clin Res Cardiol; 2016 Mar; 105(3):230-8. PubMed ID: 26329585
[TBL] [Abstract][Full Text] [Related]
18. Second-generation versus first-generation drug-eluting stents for the treatment of patients with acute coronary syndromes and obstructive coronary artery disease.
Machado C; Raposo L; Dores H; Leal S; Campante Teles R; de Araújo Gonçalves P; Mesquita Gabriel H; Almeida M; Mendes M
Coron Artery Dis; 2014 May; 25(3):208-14. PubMed ID: 24419038
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
[TBL] [Abstract][Full Text] [Related]
20. Long-term luminal change after drug-eluting stent implantation: serial angiographic follow-up study of the ZEST randomized trial.
Park GM; Park DW; Kim YG; Cho SW; Sun BJ; Hwang KW; Kim YR; Ahn JM; Song HG; Kim WJ; Lee JY; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2013 Feb; 81(2):274-82. PubMed ID: 22431305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
